On Friday 07/19/2024 the closing price of the Tenet Healthcare Corp share was $131.76 on BTT.
Compared to the opening price on Friday 07/19/2024 on BTT of $132.84, this is a drop of 0.82%.
Tenet Healthcare Corp's market capitalization is $13.03 B by 97.68 M shares outstanding.
Is Tenet Healthcare stock a Buy, Sell or Hold?
Tenet Healthcare stock has received a consensus rating of buy. The average rating score is and is based on 65 buy ratings, 11 hold ratings, and 0 sell ratings.What was the 52-week low for Tenet Healthcare stock?
The low in the last 52 weeks of Tenet Healthcare stock was 51.12. According to the current price, Tenet Healthcare is 260.92% away from the 52-week low.What was the 52-week high for Tenet Healthcare stock?
The high in the last 52 weeks of Tenet Healthcare stock was 142.30. According to the current price, Tenet Healthcare is 93.73% away from the 52-week high.What are analysts forecasts for Tenet Healthcare stock?
The 76 analysts offering price forecasts for Tenet Healthcare have a median target of 93.67, with a high estimate of 156.00 and a low estimate of 45.00. The median estimate represents a 142.40 difference from the last price of 133.38.Tenet Healthcare Stock Snapshot
133.27
Bid
5.00
Bid Size
133.71
Ask
100.00
Ask Size
7/19/2024
Date
3:59 PM
Time
30,074.00
Volume
131.76
Prev. Close
132.84
Open
97.68 M
Number of Shares
131.59
Day Low
134.15
Day High
133.38
51.12
52 Week Low
142.30
52 Week High
133.38
0.00
Dividend in USD
0.00
Dividend Yield
12.96
P/E Ratio
97.42
Free Float in %
6.01
EPS in USD
16.09
Book Value per Share in USD
22.65
Cash Flow per Share in USD
Tenet Healthcare News More News
Historical Prices for Tenet Healthcare
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Tenet Healthcare Analyst Data
Total Analysts: 76
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 45.00
Median: 93.67
Highest: 156.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Tenet Healthcare Analyst Opinions
- All
- Buy
- Hold
- Sell
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
07/10/24 | Barclays Capital | Maintained Buy | $156 | |||
07/09/24 | Cantor Fitzgerald | Maintained Buy | $112 | |||
07/02/24 | Cantor Fitzgerald | Maintained Buy | $112 | |||
06/28/24 | Deutsche Bank | Maintained Buy | $155 | |||
05/30/24 | J.P. Morgan | Maintained Buy | $140 | |||
05/30/24 | Deutsche Bank | Maintained Buy | $150 | |||
05/30/24 | Baird Patrick & Co | Maintained Buy | $153 | |||
05/02/24 | Barclays Capital | Maintained Buy | $147 | |||
05/01/24 | RBC Capital Markets | Maintained Buy | $136 | |||
05/01/24 | UBS | Maintained Buy | $150 | |||
05/01/24 | Mizuho | Maintained Buy | $130 | |||
05/01/24 | Stephens Inc. | Maintained Hold | $122 | |||
04/12/24 | Deutsche Bank | Maintained Buy | $126 | |||
04/10/24 | Cantor Fitzgerald | Maintained Buy | $104 | |||
03/28/24 | Wells Fargo & Co | Maintained Buy | $115 | |||
03/27/24 | Wolfe Research | Upgraded to Buy | $122 | |||
03/11/24 | Mizuho | Maintained Buy | $110 | |||
03/06/24 | Barclays Capital | Maintained Buy | $113 | |||
03/05/24 | Cantor Fitzgerald | Maintained Buy | $104 | |||
02/15/24 | Wells Fargo & Co | Maintained Buy | $105 | |||
02/09/24 | RBC Capital Markets | Maintained Buy | $109 | |||
02/09/24 | Mizuho | Maintained Buy | $100 | |||
02/09/24 | Cantor Fitzgerald | Maintained Buy | $104 | |||
11/17/23 | J.P. Morgan | Maintained Buy | $81 | |||
11/14/23 | Jefferies & Company Inc. | Maintained Buy | $85 | |||
11/09/23 | Goldman Sachs | Maintained Buy | $85 | |||
11/02/23 | UBS | Maintained Buy | $94 | |||
11/01/23 | Raymond James Financial, Inc. | Maintained Buy | $90 | |||
10/31/23 | Mizuho | Maintained Buy | $77 | |||
10/31/23 | RBC Capital Markets | Maintained Buy | $72 | |||
10/20/23 | Wells Fargo & Co | Maintained Buy | $71 | |||
09/14/23 | Cantor Fitzgerald | Maintained Buy | $94 | |||
08/14/23 | Goldman Sachs | Maintained Buy | $98 | |||
08/02/23 | Credit Suisse | Maintained Buy | $98 | |||
08/02/23 | Raymond James Financial, Inc. | Maintained Buy | $95 | |||
08/01/23 | UBS | Maintained Buy | $104 | |||
08/01/23 | RBC Capital Markets | Maintained Buy | $87 | |||
08/01/23 | Stephens Inc. | Maintained Hold | $89 | |||
08/01/23 | Citigroup Corp. | Maintained Buy | $90 | |||
07/11/23 | Mizuho | Maintained Buy | $94 | |||
06/14/23 | Jefferies & Company Inc. | Maintained Buy | $95 | |||
05/16/23 | Mizuho | Maintained Buy | $81 | |||
04/26/23 | Deutsche Bank | Maintained Buy | $81 | |||
04/26/23 | RBC Capital Markets | Maintained Buy | $84 | |||
04/26/23 | Raymond James Financial, Inc. | Maintained Buy | $85 | |||
04/26/23 | Stephens Inc. | Maintained Hold | $77 | |||
04/26/23 | Barclays Capital | Maintained Buy | $105 | |||
04/21/23 | Cantor Fitzgerald | Maintained Buy | $73 | |||
04/19/23 | J.P. Morgan | Maintained Buy | $72 | |||
02/22/23 | Stephens Inc. | Maintained Hold | $64 |
Tenet Healthcare Estimates* in USD
2024 | 2025 | 2026 | 2027 | |
---|---|---|---|---|
Revenue | 20,391 | 21,262 | 22,312 | - |
Dividend | 0.00 | 0.80 | 0.00 | - |
Dividend Yield (in %) | 0.00 % | 0.60 % | 0.00 % | - |
EPS | 8.81 | 9.25 | 10.43 | - |
P/E Ratio | 15.14 | 14.42 | 12.79 | 15.16 |
EBIT | 2,878 | 2,893 | 3,104 | - |
EBITDA | 3,643 | 3,810 | 4,088 | - |
Net Profit | 882 | 916 | 1,012 | - |
Net Profit Adjusted | 882 | 918 | 1,017 | - |
Pre-Tax Profit | 2,050 | 2,110 | 2,315 | - |
Net Profit (Adjusted) | 3,166 | 1,787 | 1,824 | - |
EPS (Non-GAAP) ex. SOE | 8.81 | 9.25 | 10.43 | - |
EPS (GAAP) | 28.15 | 9.07 | 10.21 | - |
Gross Income | 7,734 | 8,027 | 8,546 | - |
Cash Flow from Investing | -932 | -485 | -167 | - |
Cash Flow from Operations | 1,920 | 2,314 | 2,516 | - |
Cash Flow from Financing | -932 | -485 | -167 | - |
Cash Flow per Share | 19.33 | 21.78 | 20.60 | - |
Free Cash Flow | 886 | 1,297 | 1,417 | - |
Free Cash Flow per Share | 7.31 | 11.29 | 13.24 | - |
Book Value per Share | 55.15 | 63.75 | 73.44 | - |
Net Debt | 9,321 | 9,075 | 8,066 | - |
Research & Development Exp. | - | - | - | - |
Capital Expenditure | 817 | 847 | 870 | - |
Selling, General & Admin. Exp. | 4,383 | 4,553 | - | - |
Shareholder’s Equity | 4,721 | 6,515 | 7,042 | - |
Total Assets | 29,527 | 30,811 | 33,659 | - |
Previous Quarter ending 06/30/24 |
Current Quarter ending 09/30/24 |
Next Quarter ending 12/31/24 |
Current Year ending 12/31/24 |
Next Year ending 12/31/25 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | 17 | 17 | 17 | 17 | 17 |
Average Estimate | 1.897 USD | 1.672 USD | 2.252 USD | 8.808 USD | 9.247 USD |
Year Ago | 1.209 USD | 0.995 USD | 2.417 USD | 6.012 USD | - |
Publish Date | 7/24/2024 | 10/17/2024 | 2/6/2025 | - | - |
Revenue Estimates | |||||
No. of Analysts | 17 | 17 | 17 | 19 | 17 |
Average Estimate | 4,989 USD | 4,886 USD | 5,171 USD | 20,391 USD | 21,262 USD |
Year Ago | 5,082 USD | 5,066 USD | 5,379 USD | 20,548 USD | - |
Publish Date | 7/24/2024 | 10/17/2024 | 2/6/2025 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales | 20,548.00 | 19,174.00 | 19,485.00 | 17,640.00 | 18,479.00 | 18,313.00 | 19,179.00 |
Change of sales in % | 7.17 | -1.60 | 10.46 | -4.54 | 0.91 | -4.52 | -2.25 |
Gross profit on sales | 2,427.00 | 2,274.00 | 2,259.00 | 1,286.00 | 1,679.00 | 1,614.00 | 1,380.00 |
Gross profit on sales change in % | 6.73 | 0.66 | 75.66 | -23.41 | 4.03 | 16.96 | -1.43 |
Operating income | 2,427.00 | 2,218.00 | 2,218.00 | 1,258.00 | 1,679.00 | 1,614.00 | 1,380.00 |
Operating income change in % | 9.42 | 0.00 | 76.31 | -25.07 | 4.03 | 16.96 | -1.43 |
Income before tax | 1,617.00 | 1,344.00 | 1,888.00 | 671.00 | 296.00 | 639.00 | -101.00 |
Income before tax change in % | 20.31 | -28.81 | 181.37 | 126.69 | -53.68 | - | - |
Income after tax | 611.00 | 411.00 | 914.00 | 399.00 | -232.00 | 111.00 | -704.00 |
Income after tax change in % | 48.66 | -55.03 | 129.07 | - | - | - | -266.67 |
Balance Sheet in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Total liabilities | 22,804.00 | 22,548.00 | 23,322.00 | 24,217.00 | 21,362.00 | 20,302.00 | 20,980.00 |
Long-term liabilities per share | 180.53 | 176.75 | 169.91 | 182.62 | 164.66 | - | 164.88 |
Equity | 5,508.00 | 4,608.00 | 4,257.00 | 2,889.00 | 1,989.00 | 2,107.00 | 2,405.00 |
Equity change in % | 40.81 | 11.09 | 3,571.43 | - | -211.76 | 19.05 | -135.25 |
Balance sheet total | 28,312.00 | 27,156.00 | 27,579.00 | 27,106.00 | 23,351.00 | 22,409.00 | 23,385.00 |
Balance sheet total change in % | 4.26 | -1.53 | 1.75 | 16.08 | 4.20 | -4.17 | -5.33 |
Key Data in USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales per share | 196.07 | 173.50 | 179.47 | 166.00 | 178.72 | 176.29 | 190.66 |
P/E ratio (year end quote, basic EPS) | 12.96 | 13.12 | 9.70 | 10.63 | - | 16.04 | - |
P/E ratio (year end quote, diluted EPS) | 12.96 | 13.12 | 9.70 | 10.63 | - | 16.04 | - |
P/E ratio (year end quote) | 12.96 | 13.12 | 9.70 | 10.63 | - | 16.04 | - |
Dividend yield in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity ratio in % | 5.68 | 4.21 | 3.73 | 0.10 | -1.59 | -0.53 | -0.63 |
Debt ratio in % | 80.55 | 83.03 | 84.56 | 89.34 | 91.48 | 90.60 | 89.72 |
Tenet Healthcare Insider Activity
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Sutaria Saumya | 06/09/2024 | 100,000.00 | 271,521.00 | n/a | Sell | No |
FISHER RICHARD W | 06/09/2024 | 1,400.00 | 16,227.00 | 132.24 | Sell | No |
Sutaria Saumya | 06/09/2024 | 100,000.00 | 100,000.00 | n/a | Buy | No |
KERREY J ROBERT | 05/30/2024 | 104.00 | n/a | 135.17 | Sell | No |
KERREY J ROBERT | 05/30/2024 | 8,699.00 | 801.00 | 133.30 | Sell | No |
KERREY J ROBERT | 05/30/2024 | 697.00 | 104.00 | 134.44 | Sell | No |
KERREY J ROBERT | 05/29/2024 | 9,500.00 | 36,903.00 | n/a | Sell | No |
KERREY J ROBERT | 05/29/2024 | 7,964.00 | 46,403.00 | 134.65 | Sell | No |
KERREY J ROBERT | 05/29/2024 | 6,358.00 | 54,367.00 | 133.20 | Sell | No |
Lynch Christopher S. | 05/29/2024 | 10,861.00 | 14,759.00 | 133.83 | Sell | No |
KERREY J ROBERT | 05/29/2024 | 9,500.00 | 9,500.00 | n/a | Buy | No |
West Nadja | 05/08/2024 | 1,782.00 | 29,680.00 | 126.41 | Sell | No |
FISHER RICHARD W | 05/06/2024 | 2,500.00 | 17,627.00 | 123.20 | Sell | No |
Arnst Thomas W | 04/30/2024 | 300.00 | 200.00 | 118.80 | Sell | No |
Arnst Thomas W | 04/30/2024 | 531.00 | 7,617.00 | 113.76 | Sell | No |
Arnst Thomas W | 04/30/2024 | 200.00 | n/a | 119.81 | Sell | No |
Arnst Thomas W | 04/30/2024 | 2,915.00 | 2,900.00 | 115.98 | Sell | No |
Arnst Thomas W | 04/30/2024 | 1,802.00 | 5,815.00 | 114.87 | Sell | No |
Arnst Thomas W | 04/30/2024 | 2,000.00 | 900.00 | 116.89 | Sell | No |
Arnst Thomas W | 04/30/2024 | 400.00 | 500.00 | 117.82 | Sell | No |
Sutaria Saumya | 04/04/2024 | 125,000.00 | 371,521.00 | n/a | Sell | No |
MARK RICHARD J | 03/11/2024 | 14,000.00 | 33,303.00 | 98.98 | Sell | No |
Arbour Paola M | 03/05/2024 | 18,168.00 | 29,803.00 | 96.96 | Sell | No |
Foo Lisa Y | 02/29/2024 | 1,890.00 | 19,566.00 | 94.29 | Sell | No |
Foo Lisa Y | 02/29/2024 | 4,198.00 | 21,456.00 | n/a | Buy | No |
Tenet Healthcare Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2023 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2022 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2021 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2020 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2019 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2018 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2017 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2016 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2015 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2014 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2013 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2012 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2011 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2010 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2009 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2008 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2007 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2006 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2005 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
2004 | Tenet Healthcare Corp | 0.00 | 0.00 | USD |
*Yield of the Respective Date
Tenet Healthcare Corp Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 1.897 USD | Q2 2024 Earnings Release | 07/24/2024 |
Earnings Report | 1.672 USD | Q3 2024 Earnings Release | 10/17/2024 |
Earnings Report | 2.252 USD | Q4 2024 Earnings Release | 02/06/2025 |
Earnings Report | 2.536 USD | Q1 2025 Earnings Release | 04/16/2025 |
Earnings Report | 2.200 USD | Q2 2025 Earnings Release | 07/17/2025 |
Tenet Healthcare Corp Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Annual General Meeting | - | Annual General Meeting | 05/22/2024 |
Tenet Healthcare Profile
Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.
Moody’s Daily Credit Risk Score
Tenet Healthcare Shareholder
Owner | in % |
---|---|
Freefloat | 97.42 |
The Vanguard Group, Inc. | 11.37 |
Vanguard Group, Inc. (Subfiler) | 11.00 |
T Rowe Price Associates, Inc. (13F Subfiler) | 7.98 |
Glenview Capital Management LLC | 7.93 |
T. Rowe Price Associates, Inc. (Investment Management) | 7.30 |
Glenview Capital Management LLC | 6.48 |
BlackRock Fund Advisors | 5.31 |
Invesco Advisers, Inc. | 4.54 |
BlackRock Institutional Trust Co. NA | 3.21 |
Vanguard Total Stock Market ETF | 3.16 |
State Street Corp. | 3.12 |
iShares Core S&P Mid Cap ETF | 3.11 |
Vanguard Small Cap Index Fund | 2.51 |
T Rowe Price Value Fund | 2.09 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.